IKU allows anyone in the world to create, license, and trade bio r&d as fundable data assets. All IKU hosted projects are vetted with A.I. and the wisdom of the medical crowd.
Interesting...Tell me more
IKU is a decentralized autonomous organization for funding and developing bio r&d and clinical trials, OPEN TO THE WORLD. The IKU architecture leverages blockchain to create global license markets for bio IP, and an A.I. Neural Network to derisk those markets. Our goal is to accelerate drug discovery and biotech innovation so we all can reap the benefits.
We employ the Stanford University SPARK MONEYBALL strategy - driving undervalued r&D into the market - which has generated an additional 1,000% follow-on funding for SPARK funded r&d. SPARK prioritizes science, a complete 180 from the Big Pharma approach, and has generated unprecedented results. IKU has vetted this strategy with SPARK and its time for blast off.
Unlock IKU with our user token.
Access the crowd-fund, proposal, and development features.
Collaborate in a biotech digital commons.
Crowdfund and commoditize your research.
Vet research with A.I. and Stanford SPARK.
License research and trade as a commodity.
Encrypt, store, and access r&d data on IPFS.
Enforce & monitor development.
Contribute to research.
Earn royalties based on contributed work - Proof of Work.
Reward the IKU network for crowdfunding.
Create & service bounties.
IKU is solving for an illiquid, centralized, and broken R&D model that is silo’d and closed to the public. IKU gives you the opportunity to sponsor and accelerate bio innovation.